Editorial draft — not for publication yet. Alprazolam content needs clinical and legal review before publication. This is general information, not a legal decision about a product or action.
Quick answer
Opsonin’s Alprax product insert lists management of anxiety disorder, including generalised anxiety disorder, short-term relief of excessive anxiety, panic disorder with or without agoraphobia, and anxiety associated with depression. These are the indications stated in that Bangladesh manufacturer document; they should not automatically be read as a UK treatment recommendation for Alprax XR 1 mg.
For general active-ingredient information, read the Alprazolam medicine guide.
The manufacturer insert lists anxiety-related indications for Alprax XR
The UK product information for Xanax tablets, which also contain alprazolam, describes short-term symptomatic treatment of anxiety in adults only when it is severe, disabling or causing extreme distress. It is a different product record and does not establish the authorisation or use instructions for Alprax XR.
NICE guidance puts important limits on benzodiazepines
NICE says benzodiazepines should not usually be offered for generalised anxiety disorder in primary or secondary care, except temporarily as a short-term measure during a crisis. For panic disorder, NICE advises against benzodiazepines because of poorer long-term outcomes.
This distinction matters: a product insert’s listed indication and a national clinical guideline answer different questions. Neither a search result nor a brand name can determine whether alprazolam is suitable for an individual. A UK clinician should assess symptoms, explain options and agree a review and stopping plan if a benzodiazepine is prescribed.
For ongoing anxiety, ask about care beyond a sedative
If anxiety continues, returns, affects sleep or is not improving, arrange a review rather than increasing the amount or extending treatment yourself. NICE describes psychological approaches and other treatment options for ongoing anxiety; the right choice depends on diagnosis, preferences, health history and previous care.
Tell the clinician about alcohol or drug use, breathing problems, low mood, pregnancy, other medicines and any previous difficulty stopping a sedative. If you feel at immediate risk of harming yourself, contact emergency services or a crisis service now.
Need help in the UK? Call 999 for a life-threatening emergency. For urgent medical advice that is not an emergency, contact NHS 111. Ask a pharmacist or prescriber about your specific medicine.
Frequently asked questions
Does Alprax XR treat anxiety?
Opsonin’s Bangladesh insert lists anxiety-related indications. That is not automatically a UK recommendation or confirmation that Alprax XR is a UK-authorised product; UK guidance and an individual assessment matter.
Does NICE recommend alprazolam for generalised anxiety?
NICE says benzodiazepines should not usually be offered for GAD, except temporarily as a short-term measure during a crisis.
Is Alprax XR recommended for panic attacks in the UK?
NICE advises against benzodiazepines for panic disorder because of poorer long-term outcomes. Discuss recurrent panic symptoms with a UK healthcare professional.
Sources and further reading
This draft draws on brand or manufacturer product information and UK sources below. Product information is market-specific; check the leaflet supplied with your exact product.
- Opsonin Pharma Limited, Bangladesh: Alprax and Alprax XR manufacturer product insert
- electronic Medicines Compendium: Xanax 500 microgram tablets: UK Summary of Product Characteristics
- NICE: Generalised anxiety disorder and panic disorder recommendations
Editorial status: Editorial draft — clinical and regulatory review required before publication. Sources checked on 3 October 2026.
Related information
Read the Alprax XR 1 mg product overview or continue to another topic: